President Trump nominated White House domestic policy aide Dr. Heidi Overton on August 19, 2026, to serve as FDA commissioner following the May resignation of Dr. Marty Makary. The Senate Health, Education, Labor and Pensions Committee must first advance the nomination before a full Senate vote. Committee chairman Sen. Bill Cassidy voiced immediate strong reservations over Overton’s involvement in a recent executive order on childhood vaccines, describing it as nearly disqualifying and signaling potential hurdles even among Republicans. Democratic members, including Sen. Patty Murray, have signaled opposition. Confirmation would require navigating committee scrutiny and securing sufficient Republican support in a process that can shift with additional statements or hearing developments.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert$14,094 Vol.
30. September
21%
31. Oktober
35%
30. November
36%
31. Dezember
40%
$14,094 Vol.
30. September
21%
31. Oktober
35%
30. November
36%
31. Dezember
40%
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Markt eröffnet: Aug 20, 2026, 5:43 PM ET
Resolver
0x65070BE91...If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...President Trump nominated White House domestic policy aide Dr. Heidi Overton on August 19, 2026, to serve as FDA commissioner following the May resignation of Dr. Marty Makary. The Senate Health, Education, Labor and Pensions Committee must first advance the nomination before a full Senate vote. Committee chairman Sen. Bill Cassidy voiced immediate strong reservations over Overton’s involvement in a recent executive order on childhood vaccines, describing it as nearly disqualifying and signaling potential hurdles even among Republicans. Democratic members, including Sen. Patty Murray, have signaled opposition. Confirmation would require navigating committee scrutiny and securing sufficient Republican support in a process that can shift with additional statements or hearing developments.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert



Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen